Damien Amelin
Ingénieur d'études
Titres
Ingénieur d'études
Expertises
- Culture cellulaire
- Cytométrie de Flux
- Myopathies Inflammatoires
- Immunologie
Présentation
Ingénieur d’étude dans l’équipe Muscle Inflammatoire et Thérapies Innovantes Ciblées dirigée par le Pr Olivier Benveniste.
Principales publications
- Dzangué-Tchoupou, G, Mariampillai, K, Bolko, L, Amelin, D, Mauhin, W, Corneau, A et al.. CD8+T-bet+ cells as a predominant biomarker for inclusion body myositis. Autoimmun Rev. 2019;18 (4):325-333. doi: 10.1016/j.autrev.2019.02.003. PubMed PMID:30825520 .
- Mariampillai, K, Granger, B, Amelin, D, Guiguet, M, Hachulla, E, Maurier, F et al.. Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies. JAMA Neurol. 2018;75 (12):1528-1537. doi: 10.1001/jamaneurol.2018.2598. PubMed PMID:30208379 PubMed Central PMC6583199.
- Mauhin, W, Lidove, O, Amelin, D, Lamari, F, Caillaud, C, Mingozzi, F et al.. Deep characterization of the anti-drug antibodies developed in Fabry disease patients, a prospective analysis from the French multicenter cohort FFABRY. Orphanet J Rare Dis. 2018;13 (1):127. doi: 10.1186/s13023-018-0877-4. PubMed PMID:30064518 PubMed Central PMC6069887.
- Ladislau, L, Suárez-Calvet, X, Toquet, S, Landon-Cardinal, O, Amelin, D, Depp, M et al.. JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis. Brain. 2018;141 (6):1609-1621. doi: 10.1093/brain/awy105. PubMed PMID:29741608 .
- Arouche-Delaperche, L, Allenbach, Y, Amelin, D, Preusse, C, Mouly, V, Mauhin, W et al.. Pathogenic role of anti-signal recognition protein and anti-3-Hydroxy-3-methylglutaryl-CoA reductase antibodies in necrotizing myopathies: Myofiber atrophy and impairment of muscle regeneration in necrotizing autoimmune myopathies. Ann Neurol. 2017;81 (4):538-548. doi: 10.1002/ana.24902. PubMed PMID:28224701 .